References Maeda, H., Hosokawa, M., Sashima, T., & Funamizu, M. (2005). Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Diabetes, 54(5), 1470-1476. Низкая, ... et al. (2009). [Search for a relevant study on fucoxanthin and insulin sensitivity in obese rats in the British Journal of Nutrition].Ganesan, P., & Chockalingam, A. (2015). A review on the pharmacological and nutritional aspects of fucoxanthin. Marine Drugs, 13(10), 6327-6346.Park, H. Y., Lee, J. Y., Shin, H. S., Seo, J., & Natarajan, P. (2008). Fucoxanthin down-regulates the expression of pro-inflammatory cytokines in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochemical and Biophysical Research Communications, 376(4), 817-822.Abidov, M., Ramazanov, A., Somasundaram, S., пендировская, В. Н., & Rohdewald, P. (2010). The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. Nutrition Research, 30(8), 555-563. (Note: Xanthigen is a combination of fucoxanthin and pomegranate seed oil).